Gufic Biosciences to manufacture, sell, distribute Isavuconazonium Sulfate API & finished formulation Isavuconazole

11 Apr 2022 Evaluate

Gufic Biosciences has received permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare for manufacture, sale and distribution of Isavuconazonium Sulfate API and finished formulation Isavuconazole for Injection 200 mg/vial. Isavuconazole for Injection 200 mg/vial is indicated for the treatment of patients having 18 years of age and older for the treatment of Invasive Aspergillosis and Invasive Mucormycosis.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.


Gufic Biosciences Share Price

348.40 -3.05 (-0.87%)
17-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.95
Dr. Reddys Lab 1271.00
Cipla 1497.45
Zydus Lifesciences 917.85
Lupin 2109.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×